ASP2998
/ Astellas
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 18, 2025
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=428 | Not yet recruiting | Sponsor: Astellas Pharma Global Development, Inc.
Monotherapy • New P1/2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Urothelial Cancer
1 to 1
Of
1
Go to page
1